Close

Altamira Therapeutics Announces Launch Of Bentrio In Hong Kong By Its Partner Nuance Pharma

Published on December 01, 2022 01:39 AM AEDT

Nov 30 (Reuters) - Altamira Therapeutics Ltd:

* ALTAMIRA THERAPEUTICS ANNOUNCES LAUNCH OF BENTRIO IN HONG KONG BY ITS PARTNER NUANCE PHARMA

* ALTAMIRA THERAPEUTICS LTD - NUANCE PHARMA TO FILE FOR MARKETING APPROVAL IN MACAO, MAINLAND CHINA AND SOUTH KOREA IN 2023

* ALTAMIRA THERAPEUTICS LTD - UPON REACHING CERTAIN MILESTONES, NUANCE WILL ASSUME LOCAL PRODUCTION OF BENTRIO FOR ITS LICENSED TERRITORY

* ALTAMIRA THERAPEUTICS - UPON REACHING CERTAIN MILESTONES, NUANCE WILL PAY TO CO A STAGGERED ROYALTY AT A HIGH-SINGLE TO LOW-DOUBLE DIGIT PERCENTAGE Source text for Eikon: Further company coverage:

Reuters

Reuters -
90350 Posts
...

Disclaimer

The above content is directly sourced from Reuters under a contractual arrangement. The content is being provided as a convenience and for informational purposes only; and does not constitute an endorsement or approval by Kalkine Media of any of the products, services, or opinions of the organization or individual. The user is apprised that Kalkine Media bears no responsibility for the accuracy, legality, or content of Reuters, any external sites, or for that of subsequent links. The user is requested to contact Reuters directly for answers to questions regarding the content. Please note that Kalkine Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.